Methods in Medicines evaluation & Outcomes research (M2O)

University of Groningen > Faculty of Medical Sciences > Science in Healthy Ageing & healthcaRE (SHARE) > Methods in Medicines evaluation & Outcomes research (M2O)

  1. 2018
  2. 2017
  3. van Tilborg, T. C., Oudshoorn, S. C., Eijkemans, M. J. C., Mochtar, M. H., van Golde, R. J. T., Hoek, A., ... OPTIMIST study group (2017). Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis. Human Reproduction, 32(12), 2485-2495. DOI: 10.1093/humrep/dex321
  4. Oudshoorn, S. C., van Tilborg, T. C., Eijkemans, M. J. C., Oosterhuis, G. J. E., Friederich, J., van Hooff, M. H. A., ... OPTIMIST study group (2017). Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder. Human Reproduction, 32(12), 2506-2514. DOI: 10.1093/humrep/dex319
  5. van Tilborg, T. C., Torrance, H. L., Oudshoorn, S. C., Eijkemans, M. J. C., Koks, C. A. M., Verhoeve, H. R., ... OPTIMIST study group (2017). Individualized versus standard FSH dosing in women starting IVF/ICSI an RCT. Part 1: The predicted poor responder. Human Reproduction, 32(12), 2496-2505. DOI: 10.1093/humrep/dex318
  6. van Vark, L. C., Lesman-Leegte, I., Baart, S. J., Postmus, D., Pinto, Y. M., de Boer, R. A., ... TRIUMPH (Translational Initiative on Unique and Novel Strategies for Management of Patients with Heart Failure) Investigators (2017). Prognostic Value of Serial Galectin-3 Measurements in Patients With Acute Heart Failure. Journal of the American Heart Association, 6(12). DOI: 10.1161/JAHA.116.003700
  7. Suijkerbuijk, A. W. M., van Gils, P. F., Bonačić Marinović, A. A., Feenstra, T. L., Kortbeek, L. M., Mangen, M-J. J., ... van der Giessen, J. W. B. (2017). The design of a Social Cost-Benefit Analysis of preventive interventions for toxoplasmosis: An example of the One Health approach. Zoonoses and Public Health. DOI: 10.1111/zph.12417
  8. Vanholder, R., Annemans, L., Brown, E., Gansevoort, R., Gout-Zwart, J. J., Lameire, N., ... European Kidney Health Alliance (2017). Further approaches to reduce the cost of renal replacement therapy. Nature Reviews Nephrology, 13(11). DOI: 10.1038/nrneph.2017.136
  9. Pontillo, C., Zhang, Z-Y., Schanstra, J. P., Jacobs, L., Zürbig, P., Thijs, L., ... Jankowski, J. (2017). Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker. Kidney International Reports, 2(6), 1066-1075. DOI: 10.1016/j.ekir.2017.06.004
  10. Cherney, D., Perkins, B. A., Lytvyn, Y., Heerspink, H., Rodriguez-Ortie, M. E., & Mischak, H. (2017). The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome. Plos one, 12(10), [0186910]. DOI: 10.1371/journal.pone.0186910
  11. Levin, A., Tonelli, M., Bonventre, J., Coresh, J., Donner, J-A., Fogo, A. B., ... ISN Global Kidney Health Summit participants (2017). Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. The Lancet, 390(10105), 1888-1917. DOI: 10.1016/S0140-6736(17)30788-2
  12. Pozhidaev, I., Alifirova, V. M., Freidin, M. B., Zhukova, I. A., Fedorenko, O. Y., Osmanova, D. Z., ... Loonen, A. J. M. (2017). Dopamine receptors genes polymorphisms in Parkinson patients with levodopa-induced dyskinesia. European Neuropsychopharmacology, 27(Supplement 4), S590. DOI: 10.1016/S0924-977X(17)31129-X
  13. Ivanova, S. A., Alifirova, V. M., Freidin, M. B., Pozhidaev, I. V., Fedorenko, O. Y., Bokhan, N. A., ... Loonen, A. J. M. (2017). Predictive genetic model for levodopa-induced dyskinesia in patients with Parkinson's disease. European Neuropsychopharmacology, 27(Supplement 4), S1039-S1040. DOI: 10.1016/S0924-977X(17)31817-5
  14. Pozhidaev, I., Alifirova, V. M., Freidin, M. B., Zhukova, I. A., Fedorenko, O. Y., Osmanova, D. Z., ... Loonen, A. J. M. (2017). Dopamine receptors genes polymorphisms in Parkinson patients with levodopa-induced dyskinesia. European Neuropsychopharmacology, 27, S590-S590.
  15. Ivanova, S. A., Alifirova, V. M., Freidin, M. B., Pozhidaev, I. V., Fedorenko, O. Y., Bokhan, N. A., ... Loonen, A. J. M. (2017). Predictive genetic model for levodopa-induced dyskinesia in patients with Parkinson's disease. European Neuropsychopharmacology, 27, S1039-S1040.
  16. Luyckx, V. A., Tuttle, K. R., Garcia-Garcia, G., Gharbi, M. B., Heerspink, H. J. L., Johnson, D. W., ... White, S. L. (2017). Reducing major risk factors for chronic kidney disease. Kidney international supplements, 7(2), 71-87. DOI: 10.1016/j.kisu.2017.07.003
Previous 1 2 3 4 5 6 7 8 ...47 Next

ID: 37766